Beruflich Dokumente
Kultur Dokumente
A N E V I D E N C E - B A S E D A P P ROAC H T O E M E RG E N C Y M E D I C I N E
April 2000
Allergic Emergencies
and Anaphylaxis:
How To Avoid Getting Stung
Volume 2, Number 4
Authors
LLERGIC reactions span a wide spectrum of clinical presentationsfrom the minor irritant of hay fever to the dramatic systemic
disruption known as anaphylaxis. Recognizing allergic phenomena can
be a challenge. While urticaria represents an obvious hypersensitivity
reaction, distinguishing an allergic etiology of syncope or chest pain is
more difficult. Many serious allergic reactions present with atypical
symptoms, making immediate diagnosis difficult.
Emergency physicians are often faced with difficult management
decisions surrounding allergic reactions. When should patients with ACE
inhibitor angioedema be admitted, or even prophylactically intubated?
How does one manage recurrent urticaria?
This issue of Emergency Medicine Practice suggests a plan for prompt,
effective management. Central principles include recognizing the highrisk patient, an organized approach to the seriously ill, and protecting
the patient from future allergic problems.
Editor-in-Chief
Stephen A. Colucciello, MD, FACEP,
Director of Clinical Services, Department of Emergency
Medicine, Carolinas Medical
Center, Charlotte, NC; Assistant
Clinical Professor, Department of
Emergency Medicine, University
of North Carolina at Chapel Hill,
Chapel Hill, NC.
Associate Editor
Andy Jagoda, MD, FACEP, Associate
Professor of Emergency
Medicine, Mount Sinai School of
Medicine, New York, NY.
Editorial Board
Judith C. Brillman, MD, Residency
Director, Associate Professor,
Department of Emergency
John OBrien, MD
Assistant Residency Director, Department of
Emergency Medicine, Orlando Regional Medical
Center; Clinical Assistant Professor of Medicine,
University of Florida College of Medicine, Orlando, FL.
John M. Howell, MD
Chairman, Department of Emergency
Medicine, Georgetown University Medical
Center, Washington, DC.
Peer Reviewers
David N. Zull, MD, FACEP, FACP
Associate Professor of Medicine/Associate Chief
Medicine, Northwestern University, Chicago, IL.
Joseph A. Salomone III, MD, FAAEM
Residency Director, Department of Emergency
Medicine; Associate Professor, Truman Medical Center/
UMKC School of Medicine, Kansas City, MO.
CME Objectives
Upon completing this article, you should be able to:
1. list common precipitants of allergy, both immunemediated and anaphylactoid etiologies;
2. identify appropriate therapeutic interventions for
allergic reactions;
3. discuss approaches to high-risk patients with severe
allergy and those who respond poorly to therapy;
4. describe techniques to prevent future allergic
reactions; and
5. describe indications for hospitalization of allergic
reactions, as well as appropriate outpatient
disposition techniques.
Mediator
Reaction
Immediate
II
Cytotoxic
III
Ag-Ab complexes
Immune complex
IV
T cells
Cell-mediated
T suppressor cells
Cytokines
produced
T helper cells activated
(Genetic predisposition)
B cells activated
Antigen-specific IgE
Plasma cells
April 2000
Types Of Reactions
The classic allergic reaction frequently becomes evident
seconds to minutes after exposure to a triggering antigen.
In rare situations, a delay of several hours may occur,
especially with some oral ingestions. (See Figure 3 on
page 4.) However, the sooner a reaction occurs after antigen
exposure, the more likely it is to be severe.
Although a biphasic phase of severe allergy has
been reported, there are conflicting data regarding the
importance of the delayed component. In one study of
1,261 patients with allergic reactions, only two had
late-phase recurrences, and these involved only mild
facial edema.13 In another report, 10 patients, aged 6 to
78 years, had allergic reactions one to two weeks after
an insect sting; two of them had severe anaphylactic
symptoms, including throat edema.14
Allergic reactions vary widely in severity and
depend on many factors. (See Table 2 on page 4.) These
include the degree of hypersensitivity of the individual
as well as the quantity, rate, and route of antigen
exposure. Other issues include the pattern and quantity of mediator release as well as target organ sensitivity and responsiveness.
IgE-Mediated
Antigen
Non-IgE-Mediated or Anaphylactoid
Mast Cell
or
Basophil
April 2000
Preformed
Histamine
Eosinophil Chemotactic
Factor
Neutrophil Chemotactic
Factor
Kallikreins
Others
Newly Synthesized
Leukotrienes
Prostaglandins
Platelet Activating Factor
Various Lipoxygenase
Products
Others
Table 2. Hypersensitivity
Reactions.
Mast Cell
and
Basophil
Degrees of hypersensitivity
Hours
Allergen affinity
Minutes
Late-Phase Reaction
Flushing
Eosinophil infiltration
Hypotension
Neutrophil infiltration
Fibrin deposition
Pruritis
Mononuclear infiltration
Tissue destruction
Vascular leakage
Signs/Symptoms
Percent
88%
Dyspnea, wheeze
47%
33%
30%
Flush
46%
56%
Snake antivenin
Headache
15%
Latex
Rhinitis
16%
Substernal pain
6%
4.5%
Seizure
1.5%
Non-immunologic Causes
Drugs (e.g., narcotics, neomycin, d-tubocurare, salicylates,
nonsteroidals)
Radiocontrast agents
* This list is not intended to be all-inclusive.
April 2000
Envenomations
There are slightly fewer than 100 cases of sting-related
deaths in the United States each year. Hymenoptera
(e.g., wasps, bees, and fire ants) venom precipitates
serious systemic reactions in 1-3% of patients. 18 Once a
patient has a severe systemic reaction from a Hymenoptera sting, up to 35-60% will experience anaphylaxis to a subsequent sting.19,20 Other arthropods
besides Hymenoptera can cause anaphylaxis, including
the kissing bug and a variety of ticks.
10 Allergy Pearls
7. Prevention. Prevention of further allergic reactions is
key. Referral for immunotherapy is important for
systemic hypersensitivity reactions to Hymenoptera
stings, including bees, wasps, and fire ants.
Recognition of the precipitating agent or event
requires a careful historythen educate the patient
on future avoidance.
April 2000
Latex
Radiocontrast Media
As with latex and medication allergies, anaphylaxis
due to radiocontrast media is an important iatrogenic
affliction. While the vast majority of these reactions
are not immunologic in nature, a few patients may
have an IgE-mediated component to radiocontrast
allergy.34 One to two percent of patients exposed to
these agents suffer an anaphylactoid reaction, with
fatal results in 1 per 50,000-100,000.35 This adds up to
an estimated 2667 reactions with 500 deaths annually
in the United States.36
Risk factors for radiocontrast reactions include
previous allergic reactions to these agents (35%
recurrence rate), history of atopy, shellfish allergy,
increased age, dehydration, renal or hepatic dysfunction, and cardiac disease. Other considerations
involve dye factors such as dose, osmolality, or ionic
content.37 A history of asthma or use of beta-blockers
may be among the strongest predictors of a contrastassociated reaction.38
Methods of risk reduction for radiocontrast
reactions include using another imaging technique that
does not involve these agents, using nonionic lowosmolality agents, and pre-treating 12-24 hours prior to
dye load.39 Administering diphenhydramine 1 mg/kg
every six hours and prednisone 1 mg/kg over that
period reduces the reaction rate to radiocontrast media
to under 5% for patients with previous reactions.40 One
study demonstrated a very low reaction rate if lowosmolality, non-ionic agents were used.41 However, the
costs associated with these more expensive imaging
dyes are substantial.41
Food Allergies
Illicit Drugs
Food allergies are the predominant cause of anaphylaxis seen in the ED.42 While food allergy occurs in
about 1.4% of young children and 0.3% of adults, most
reactions are minor.43
Anaphylactic reactions to foods usually occur
immediately after the food is ingested. 44 Of interest, as
many as one-third of patients with food allergy
demonstrate a biphasic reaction. Many can experience
prolonged symptoms, lasting as long as several
April 2000
weeks.45 Some food allergies occur only when particular food is followed by exercise.46 In addition to
causing urticaria or respiratory symptoms, food
allergens frequently precipitate a gastrointestinal
insurrection. Patients typically complain of nausea,
vomiting, abdominal cramping, and/or diarrhea.
Some food hypersensitivity reactions are due to
agents added during food production (e.g., penicillins
and sulfites). A limited number of foods are responsible for the vast majority of food-induced allergic
reactions. In children, the culprits include milk, eggs,
peanuts, fish, and tree nuts; in adults, prime offenders
consist of peanuts, tree nuts, fish, and shellfish. 47 As
the American palate expands toward the gourmet,
emergency physicians are seeing reactions to new
foods, such as kiwi-chamomile tea. Peanut allergies are
both common and severe, leading some airlines to stop
serving this staple as the in-flight snack. Of all allergies, however, some consider beer anaphylaxis to be
the most tragic.48
There are several interesting non-allergic food
reactions known collectively as the restaurant syndromes. The Chinese restaurant syndrome is a
reaction to MSG that consists of chest pain, facial
burning, flushing, paresthesias, sweating, dizziness,
headaches, palpitations, nausea, and vomiting. Symptoms usually begin during or shortly after the meal but
can be delayed for up to 14 hours.49
Exercise
Other poorly understood mechanisms cause direct
mediator release from allergy effector cells. Exerciseinduced allergy is usually limited to urticaria and nasal
congestion, but some reactions are fatal.39 More than
50% of patients with exercise-induced reactions have
atopy, and more than half of those with exerciseinduced anaphylaxis develop the syndrome only if
they ate just prior to marked exertion.51 Prevention
includes modifying the exercise activity, avoiding
high-risk foods within four hours of exercise, and
prophylaxis with antihistamines and leukotrienereceptor antagonists.
History
Precipitating event:
Medications, including OTCs (especially NSAIDs)
Foods (peanuts, nuts, fresh fruits, fish, shellfish,
eggs, milk)
Environmental exposures
Physical agents/events
Cardiovascular
Hypotension
Tachycardia (rarely bradycardia)
Dysrhythmias
Cardiac arrest
Previous episodes:
Frequency
Duration
Effects of treatment
Gastrointestinal tract
Abdominal colic
Vomiting (nausea)
Diarrhea
Physical Exam
Vital signs
Skin
Urticaria
Angioedema
Eyes
Conjunctivitis
Chemosis
April 2000
Physical Examination
History
Airway
Evaluate the patient for stridor, drooling, and signs of
respiratory distress. The patient in extremis may be
bolt upright, strap muscles bulging, and ribs retracting.
An inability to speak, muffled voice, or hoarseness
may reflect the need for urgent intubation. Ask the
patient to open his or her mouth, if he or she is able.
Palatal edema is an important sign that may presage
laryngeal edema. Upper airway edema is present on
autopsy in about 60% of fatal cases.54 Visualization of
the cords with a fiberoptic scope or ENT mirror may be
helpful in some cases if suspicion for laryngeal edema
is high despite a normal palate. Upper respiratory
findings in allergic reactions include rhinitis and
laryngeal edema.
Some patients with psychological problems
present with factitious stridor, known as Munchausens
stridor. These patients intentionally adduct their vocal
cords and can appear to be in profound respiratory
distress. Indirect laryngoscopy can reveal the nonanatomic nature of the stridor. Or more simply, ask the
patient to cough during the acute episode, which may
cause the stridor to disappear for a brief period.55
Breathing
The patient with laryngospasm may demonstrate a
paradoxical torso movement, with sternal collapse
accompanied by abdominal distention on inspiration.
Tachypnea may represent bronchospasm or can be due
to increased metabolic demand. Bronchospasm with
increased airway secretions reflects lower airway
involvement. Wheezing is frequent in severe reactions,
and should be distinguished from stridor, which is a
more ominous sign. Stridor tends to be loudest over
the larynx or sternal notch, while wheezing is more
prominent in the lateral fields.
Circulation
Severe hypersensitivity reactions may present with
circulatory collapse, hypoperfusion, and tachycardia.
April 2000
Laboratory Evaluation
Physical factors
Exercise
Cold, heat, sunlight
Airway disease
Reactive airway disease
Epiglottitis
Foreign body
Pulmonary embolism
Psychiatric disease
Panic attacks
Munchausens stridor
Neurologic
Vasovagal syncope
Seizure
Stroke
Cardiovascular disease
Dysrhythmias
Myocardial ischemia
Capillary leak syndrome
Drug reaction
Red man syndrome (vancomycin)
Reaction to anti-seizure medication
Flush syndromes
Carcinoid
Postmenopausal
Chlorpropamidealcohol
Medullary carcinoma thyroid
Miscellaneous
Hereditary angioedema
Progesterone anaphylaxis
Urticarial vasculitis
Pheochromocytoma
Hyperimmunoglobulin E, urticaria syndrome
Restaurant syndromes
Monosodium glutamate (MSG)
Scombroid poisoning
Sulfites
Shock
Hemorrhagic
Cardiogenic
Endotoxic
April 2000
Differential Diagnosis
A number of disorders mimic allergic reactions. (See
Table 6.) Necrotizing vasculitis, erythema multiforme,
and serum sickness may cause urticaria. Cutaneous
mastocytosis is a rare disorder that causes reddishbrown macules and papules that develop urticaria and
itching if traumatized. Systemic mastocytosis is
another rare disorder that causes episodic flushing
with or without urticaria.
Angioedema is most commonly allergy-mediated,
but it also may occur in its acquired and hereditary
forms. Hereditary angioedema is due to a deficiency of
C 1 esterase inhibitors. Hereditary angioedema is
suggested by a family history (i.e., autosomal dominant inheritance), absence of urticaria and itching,
prominence of recurrent self-limited attacks of circumcised subepithelial edema of the skin, and involvement
of the gastrointestinal tract (e.g., abdominal colic) and
upper respiratory tract (e.g., airway angioedema).59
It is usually a clinical diagnosis, because the definitive
test, a functional assay of C1 esterase inhibitor, is
not rapidly available. Recognizing hereditary angioedema is very important because it is not responsive to epinephrine, antihistamines, or corticosteroids.
Fresh frozen plasma infusion will abolish acute
episodes, and danazol reduces attack frequency.
Acquired angioedema may occur with some
lymphoproliferative disorders.
Angiotensin-converting enzyme (ACE) inhibitors
Airway
The most immediate threat to life in an allergic
reaction is upper airway obstruction. If the patient
is not profoundly hypotensive, allow him or her to
10
April 2000
recommended by older textbooks for allergic bronchospasm, there is no empiric evidence for the use of
aminophylline in anaphylaxis.
Circulation
After airway obstruction, shock is the most likely cause
of death from anaphylaxis. Hypotensive patients
require large-bore IVs and aggressive resuscitation.
Epinephrine is the drug of choice in severe allergic
emergencies. Epinephrine has alpha-agonist activity
that improves vascular tone, and beta activity that
bronchodilates and stimulates the heart. In addition,
epinephrine blocks the release of allergic mediators
through cyclic-AMP stimulation.
There are no absolute contraindications to the use of
epinephrine in a true anaphylactic emergency. Epinephrine
is safe even for older adults. In one study on asthma,
patients as old as 96 years of age were safely given
three doses of epinephrine. In this study there was no
significant difference in ventricular arrhythmias
between patients younger than 40 vs. those older than
40 years old, and the mean arterial pressure, heart rate,
and respiratory rate decreased with treatment in the
older population. 64
In mild-to-moderate reactions where peripheral
perfusion is maintained, give epinephrine subcutaneously or intramuscularly at 0.01 mg/kg (i.e., 0.1 mL/
kg) up to 0.3 to 0.5 mg (1:1000 solution=1 mg/mL).
Some authorities believe that the IM route is so
safe and effective that the subcutaneous route
should be abandoned.65
The appropriate dose, concentration, and route of
epinephrine delivery in anaphylactic shock have not
been studied. The following recommendations are
based on non-peer-reviewed, published recommendations and the experience of the authors. In more severe
reactions, give 1-5 mL of a 1:10,000 solution (0.1 mg/
mL) intravenously over two to three minutes. Alternatively, one can titrate an epinephrine infusion (1 mg in
250 cc D5W=4 mcg/cc) to symptoms and signs.66 The
low-dose titration method may be most appropriate for
patients at risk for cardiac complications from epinephrine therapy.67 Cardiac monitoring is appropriate
for all patients receiving intravenous epinephrine.68
If vascular access cannot be obtained in the
intubated patient, intratracheal dosing using 1-5 mL of
1:10,000 epinephrine can be used. Sublingual injection
of epinephrine is another consideration.
Breathing
While patients with anaphylaxis certainly demonstrate
wheezing, most profound respiratory distress is due
to upper airway problems rather than bronchospasm.
As with all aspects of anaphylaxis, epinephrine by
any route can decrease the bronchospastic component
of this disease. Inhaled epinephrine may be useful
in mitigating both bronchospasm and laryngeal
edema (i.e., 0.5 mL of epinephrine nebulized in 2.5
mL of saline).63
Other inhaled sympathomimetics such as albuterol
and metaproterenol are useful for allergy-induced
bronchospasm. Nebulized ipratropium bromide
(Atrovent) will also ameliorate bronchospasm, particularly in allergy patients on beta-blockers. While often
April 2000
Complications Of Epinephrine
Complications of epinephrine used for allergic reactions are rare. In one case, a patient was given epinephrine for a presumed allergic reaction and suffered a
fatal intracranial bleed. The crucial issue here involved
the fact that the patient was not having an allergic
reaction but was in the midst of a hypertensive crisis.
He had a blood pressure of 220/160 mmHg prior to
receiving the drug.69 In another case, a 30-year-old man
11
50 to 75 mg IV.
H 2 blockers (e.g., cimetidine), either alone or in
combination with an H1 agent, are also useful in the
treatment of allergic reactions. The best-studied H 2
antagonist is cimetidine. It is usually given in a 300 mg
dose (PO, IM, or IV). The H2 blockers offer a nonsedating alternative (or addition) to the H 1 blockers
and seem equally effective.78,79 One study of 93 patients
compared diphenhydramine and cimetidine and found
them both useful in treating acute allergic reactions.78
Runge et al found cimetidine and diphenhydramine
together more effective than either alone in treating
acute urticaria in 39 patients.80 There are also some
data indicating that cimetidine may be effective when
H 1 antihistamines are not.81
developed a myocardial infarction after self-administering an Epi-Pen for an episode of idiopathic anaphylaxis. The patient had numerous risk factors for
coronary artery disease.70 All told, there are only a
handful of cases in the English-language literature that
document adverse outcomes when epinephrine is used
to treat allergic reactions.66,68,71
Non-pharmacologic Therapy
Fluids are an important adjunct in the treatment of
anaphylaxis. Some patients with anaphylactic shock
are unresponsive to epinephrine, possibly due to
secretion of endogenous epinephrine, norepinephrine,
and production of angiotensin II.72,73
Use large volumes of IV crystalloid to resuscitate
severely allergic patients with hypoperfusion. Resuscitation may require several liters of isotonic saline or
lactated Ringer s solution to replete the intravascular
space. Avoid hypo-osmolar and dextrose-containing
solutions, which quickly ooze into the extravascular
space from the associated capillary leak syndrome.
The Pneumatic Antishock Garment (PASG)
(formerly known as MAST) has been used to treat
shock associated with allergic reactions.74,75 However,
this device has not been subject to rigorous study in
patients with anaphylaxis.
Corticosteroids
Although antihistamines may be sufficient in mild
allergic reactions, they are inadequate if used alone for
severe anaphylaxis. Corticosteroids are useful in most
allergic reactions that require an ED visit. They block
arachidonic acid production through cell membrane
stabilization; however, this effect may take several
hours. Steroids also attenuate the late-onset component
of hypersensitivity reactions, although the significance
of this component of allergy is unclear. Prednisone is
effective in the outpatient management of acute
urticaria, resolving rash and itching significantly faster
than placebo. 82 Although optimal dosing has not been
studied, prednisone 1 mg/kg/d used for three to five
days appears reasonable. This short course does not
require a tapering dose. Consider risks and benefits in
patients with diabetes mellitus or peptic ulcer disease.
Inhaled corticosteroids mitigate allergic effects isolated
to the respiratory tract and may be particularly useful
in allergic rhinitis.83
Additional Interventions
Decrease Antigen Load
If possible, eliminate the antigen or delay its absorption. (See Clinical Pathway: Treatment Of Allergic
Reactions on page 13.) If the antigenic material was
injected into an extremity, as in the case of an envenomation, some authorities suggest applying a loose
tourniquet to impede lymphatic but not arterial flow.
Bees, but not wasps, may leave a stinger in the wound,
attached to a glob of bee parts (the venom sac). If a
stinger is present, remove it by scraping rather than
compression; squeezing the venom sac can inject more
antigen. Local application of ice may delay central
antigen delivery, but it may also cause cold injury to
local tissue.
The utility of decreasing the gastric absorption of
an ingested antigen remains unknown. While the use
of charcoal seems reasonable in this situation, there is
essentially no clinical or laboratory data supporting
its use.
Glucagon
The patient with a significant hypersensitivity reaction
who is taking beta-blocker drugs poses a special
challenge. These patients often respond poorly to
epinephrine. In case of epinephrine failure, consider
the use of glucagon in these patients. This drug may
also be effective in anyone with anaphylaxis who is
unresponsive to other therapies. Glucagon bypasses
the receptors obstructed by the beta-blockers.84 Its
positive chronotropic and inotropic effects are independent of catecholamine receptors, possibly through
stimulation of cAMP synthesis.
The use of glucagon for allergic reactions in
patients taking beta-blockers is based on case reports. 85
Since glucagon is short-acting, it may be dosed at 1-2
mg IV every five minutes titrated to symptomatic
improvement. Some patients may require a glucagon
drip at 1-5 mg/h. Common side effects include
hyperglycemia, nausea, and vomiting.
Antihistamines
The use of H1-blocking antihistamines (e.g., diphenhydramine) is standard therapy in patients with allergic
reactions. The dose for mild reactions is usually
diphenhydramine or hydroxyzine 25 to 50 mg given
PO or IM. Oral alternatives with limited sedation are
cetirizine 10 mg or loratadine 10 mg.76,77
Patients with more severe reactions should be
treated with intravenous H1 antihistamines. In these
cases, most authorities recommend diphenhydramine
Continued on page 14
12
April 2000
PO charcoal
Sting, bite
Hypersensitivity
reaction
Airway
angioedema,
anaphylaxis
Allergen
exposure
H1 and/or H2 antagonist
Prednisone
Rarely epinephrine SC
Bronchospasm
Inhaled sympathomimetic
Inhaled ipratropium (Atrovent)
Consider glucagon
IV, especially if on
beta-blockers
Poor
response
Good
response
Taper epinephrine
and IV fluid
Consider disposition
Copyright 2000 Pinnacle Publishing, Inc. Pinnacle Publishing (1-800-788-1900) grants permission to reproduce this
Emergency Medicine Practice tool for institutional use.
April 2000
13
Controversies In Practice
Approach To ACE Angioedema
Angioedema is an immunologically mediated, non-IgE
edema that is generally restricted to the soft tissues of
the head and neck. Antihistamines and steroids may
not be effective in managing acute angioedema,86
leaving some patients at risk for upper airway obstruction. Many emergency physicians wonder, When
should these patients be admitted, and how should
their airways be managed? Unfortunately, there are
few data available to answer this question.
Ishoo et al retrospectively studied 93 episodes of
angioedema.87 Intubation or tracheostomy was necessary
in nine (9.7%) of the cases. Voice change, hoarseness,
stridor, and dyspnea were significantly associated with
the need for airway control. These authors suggest that
patients with facial rash, facial edema, lip edema, or soft
palate edema may be managed with supportive care and
observation. Alternatively, they suggest that patients with
laryngeal edema or progressing symptoms be admitted
to an ICU setting. In addition to being a retrospective
Continued on page 15
14
April 2000
peutic profile). Another approach is to add an H2blocker or steroids. In one double-blind, randomized,
prospective trial, adding prednisone to an antihistamine regimen shortened the clinical duration of
urticaria without apparent adverse effects.82
A crucial component to managing patients with
recurrent urticaria is education about the natural
history of allergic reactions. Tell these patients they
should expect a waxing and waning course. While the
medication may mitigate the severity of symptoms
(i.e., itching and rash), it will not completely extirpate
those symptoms. When patients have realistic expectations about their allergic reaction, they are less
likely to return to the ED.
April 2000
(continued)
15
Discharge Medications
Because some reactions are biphasic, drugs prescribed
at discharge may blunt a late allergic relapse. Prescribe
H 1 and/or H2 antagonists for at least 24 to 48 hours,
and corticosteroids for several days, to modify any
delayed inflammatory response. Montelukast and
other leukotriene-receptor antagonists may inhibit
exercise-induced anaphylaxis. 93
If a patient had a severe reaction to a food or insect
sting, prescribe self-administered injectable epinephrine (Epi-Pen or Ana-Kit, both available in adult and
pediatric strengths). Make sure the patient knows
when and how to use the device.
Summary
Allergy is a complex illness that involves inflammatory
mechanisms. Most patients with allergic reactions have
mild symptoms. However, life-threatening airway
angioedema as well as anaphylaxis require prompt
recognition and aggressive therapy. Patients in distress
require appropriate oxygenation and occasionally
intubation. Epinephrine and IV fluids remain the
mainstays of therapy for severe reactions. Give antihistamines and corticosteroids for most reactions.
Above all, treat allergic reactions with respect.
The average emergency physician will encounter
many severe hypersensitivity reactions during his
or her career.
References
1.
2.
Self-injectable epinephrine
Appropriate referral
4.
16
April 2000
5.
*6.
7.
8.
9.
10.
11.
12.
*13.
14.
15.
16.
17.
18.
19.
20.
21.
*22.
23.
24.
25.
April 2000
17
45. Sampson HA, Mendelson LM, Rosen JP. Fatal and nearfatal anaphylactic reactions to food in children and
adolescents. N Engl J Med 1992;327:380-384. (Case report; 13
patients)
46. Horan RF, Sheffer AL. Food-dependent exercise-induced
anaphylaxis. Immunol Allergy Clin North Am 1991;11:757766.
47. Sampson HA. Food allergy. Part 1: Immunopathogenesis
and clinical disorders. J Allergy Clin Immunol 1999;103(5 Pt
1):717-728. (Review)
48. Fernandez-Anaya S, Crespo JF, Rodriguez JR, et al. Beer
anaphylaxis. J Allergy Clin Immunol 1999;103(5 Pt 1):959-960.
49. Settipane GA. The restaurant syndromes. Arch Intern Med
1986;146:2129-2130.
50. Hughes JM, Merson MH. Current conceptsfish and
shellfish poisoning. N Engl J Med 1976 Nov 11;295(20):11171120.
51. Briner WW Jr, Sheffer AL. Exercise-induced anaphylaxis.
Med Sci Sports Exerc 1992;24(8):849-850. (Review)
52. Viner NA, Rhamy RK. Anaphylaxis manifested by
hypotension alone. J Urol 1975;113:108. (Case report; 3
patients)
53. Attaway NJ, Jasin HM, Sullivan TJ. Familial drug allergy. J
Allergy Clin Immunol 1991;87:227.
54. Delage C, Irey NS. Anaphylactic deaths: A clinical pathologic study of 43 cases. J Forensic Sci 1972;17:525. (Review)
55. Patterson R, Schatz M. Factitious allergic emergencies:
Anaphylaxis and laryngeal edema. J Allergy Clin Immunol
1975;56(2):152-159.
56. Fawcett WJ, Shepard JN, Soni NC, et al. Oxygen transport
and hemodynamic changes during an anaphylactoid
reaction. Anaesth Intensive Care 1994;22:300.
57. LaRoche D, Vergnaud M, Sillard B, et al. Biochemical
markers of anaphylactoid reactions to drugs. Comparison
of plasma histamine and tryptase. Anesthesiology
1991;75:945-949. (19 patients)
58. Ewan PW. Anaphylaxis. BMJ 1998;316(7142):1442-1445.
(Review)
59. Borum ML, Howard DE. Hereditary angioedema: Complex
symptoms can make diagnosis difficult. Postgrad Med
1998;103(4):251,255-256. (Review)
60. Anderson MW, deShazo RD. Studies of the mechanism of
ACE inhibitor-associated angioedema: The effect of an ACE
inhibitor on cutaneous response to bradykinin, codeine,
and histamine. J Allergy Clin Immunol 1990;85(5):856-858.
(10 patients)
61. Beltrani VS. Allergic dermatoses. Med Clin North Am
1998;82(5):1105-1133. (Review)
62. Naguib M, Malabarey T, AlSatli RA, et al. Predictive
models for difficult laryngoscopy and intubation. A clinical,
radiologic and three-dimensional computer imaging study.
Can J Anaesth 1999;46(8):748-759. (Discriminant analysis;
56 patients)
63. Heilborn H, Hjemdahl P, Daleskog M, et al. Comparison of
subcutaneous injection and high-dose inhalation of
epinephrine: implications for self-treatment to prevent
anaphylaxis. J Allergy Clin Immunol 1986;78:1174. (Comparative)
*64. Cydulka R, Davison R, Grammer L, et al. The use of
epinephrine in the treatment of older adult asthmatics. Ann
Emerg Med 1988;17(4):322-326. (Prospective; 98 patients)
65. Hughes G, Fitzharris P. Managing acute anaphylaxis: New
guidelines emphasize importance of intramuscular
adrenaline. BMJ 1999;319(7201);1-2. (Editorial)
66. Barach EM, Nowak RM, Tennyson GL. Epinephrine for
treatment of anaphylactic shock. JAMA 1984;251:2118-2122.
(Case report)
18
April 2000
April 2000
19
Class III:
Unacceptable
Not useful clinically
May be harmful
Level of Evidence:
No positive high-level data
Some studies suggest or
confirm harm
Indeterminate
Continuing area of research
No recommendations until
further research
Level of Evidence:
Evidence not available
Higher studies in progress
Results inconsistent,
contradictory
Results not compelling
20
April 2000